Rhoda Wilson

In April of this year (2022), a paper was published that demonstrated that patients who had received a lung transplant were experiencing lung transplant rejection due to what appeared to be antibody-mediated rejection.

Antibody-mediated rejection is an endothelial disorder, independent researcher Walter Chestnut wrote. “At long last, I see the bridge to the similarity of Graft vs Host disease and Covid/Long Covid/SPED (Spike Protein Endothelial Disease) … Clearly, it must be the Spike Protein.”